how many people use glp-1 drugs Poll: 1 in 8 Adults Say They Are Currently Taking a Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Are Difficult to Afford Market Overview: GLP-1 Agonists and
Description
2016;310:R885-95
Semaglutide can cause several side effects, many of which typically become less bothersome within the first few weeks of treatment
Weight loss accelerates further
Tirzepatide is not appropriate for everyone, and a responsible online clinic will conduct proper eligibility screening before prescribing
Since obesity, insulin resistance, liver fat, and metabolic dysfunction are closely linked, GLP-1 and glucagon-based combinations are being studied for their potential to reduce liver fat, improve metabolic markers, and slow disease progression
If fatigue persists despite these measures, your physician may consider adjusting your medication regimen
